Markets

Has GW Pharmaceuticals (GWPH) Outpaced Other Medical Stocks This Year?

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. GW Pharmaceuticals (GWPH) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? One simple way to answer this question is to take a look at the year-to-date performance of GWPH and the rest of the Medical group's stocks.

GW Pharmaceuticals is one of 835 individual stocks in the Medical sector. Collectively, these companies sit at #4 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.

The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. GWPH is currently sporting a Zacks Rank of #2 (Buy).

Over the past three months, the Zacks Consensus Estimate for GWPH's full-year earnings has moved 2.46% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.

Our latest available data shows that GWPH has returned about 67.53% since the start of the calendar year. Meanwhile, the Medical sector has returned an average of 6.36% on a year-to-date basis. This means that GW Pharmaceuticals is outperforming the sector as a whole this year.

Breaking things down more, GWPH is a member of the Medical - Products industry, which includes 77 individual companies and currently sits at #61 in the Zacks Industry Rank. On average, stocks in this group have gained 9.89% this year, meaning that GWPH is performing better in terms of year-to-date returns.

Investors in the Medical sector will want to keep a close eye on GWPH as it attempts to continue its solid performance.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

GW Pharmaceuticals PLC (GWPH): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More